Docetaxel versus active symptom control for refractory...

The Lancet Oncology 2014 / 01 Vol. 15; Iss. 1

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

Ford, Hugo E R, Marshall, Andrea, Bridgewater, John A, Janowitz, Tobias, Coxon, Fareeda Y, Wadsley, Jonathan, Mansoor, Wasat, Fyfe, David, Madhusudan, Srinivasan, Middleton, Gary W, Swinson, Daniel, F
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(13)70549-7
Date:
January, 2014
File:
PDF, 352 KB
english, 2014
Conversion to is in progress
Conversion to is failed